Literature DB >> 10767293

Distinctive cyclic AMP-dependent protein kinase subunit localization is associated with cyst formation and loss of tubulogenic capacity in Madin-Darby canine kidney cell clones.

S A Orellana1, C Marfella-Scivittaro.   

Abstract

Polycystic kidney disease is characterized by abnormal morphological development. Mechanisms that regulate cyst development may involve multiple signaling pathways. Cyst formation by Madin-Darby canine kidney (MDCK) cells in three-dimensional culture is assumed to be cyclic AMP-dependent and due to cyclic AMP-dependent protein kinase (cAPK) activation based on pharmacological responsiveness. To determine if different cyclic AMP (cAMP) pathways are associated with morphological development, the role of cAMP in regulating morphological change was examined in MDCK clones that form tumor-like or tubular structures under basal conditions. Pharmacological cAMP pathway activators induce cyst formation and diminish formation of other structures in three clones, whereas one clone is unaffected. Tyrosine kinase-mediated morphogens have little effect. Although all clones have intact cAMP signaling pathways, each has a unique subcellular distribution of cAPK regulatory subunits. This may reflect distinct mechanisms for cAPK anchoring, allowing cAPK subtype regulation of the unique phenotypic character of each clone through preferential access to substrates. These observations suggest a molecular basis for differential cAMP responsiveness in cells that develop distinct morphological phenotypes. This evidence establishes these MDCK clones as models for understanding the mechanism and functional significance of cAPK subunit localization and may have broader implications for cystogenesis in polycystic kidney disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10767293     DOI: 10.1074/jbc.M001964200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  The microenvironmental determinants for kidney epithelial cyst morphogenesis.

Authors:  Qiusha Guo; Bing Xia; Simon Moshiach; Congfeng Xu; Yongde Jiang; Yuanjian Chen; Yao Sun; Jill M Lahti; Xin A Zhang
Journal:  Eur J Cell Biol       Date:  2008-01-08       Impact factor: 4.492

2.  ARHGAP4 is a novel RhoGAP that mediates inhibition of cell motility and axon outgrowth.

Authors:  D L Vogt; C D Gray; W S Young; S A Orellana; A T Malouf
Journal:  Mol Cell Neurosci       Date:  2007-07-24       Impact factor: 4.314

Review 3.  Tissue-engineered kidney disease models.

Authors:  Teresa M Desrochers; Erica Palma; David L Kaplan
Journal:  Adv Drug Deliv Rev       Date:  2013-12-17       Impact factor: 15.470

4.  The absence of prostaglandin e1 returned confluent cultures of highly proliferative murine polycystic kidney principal cells to a normal proliferation level.

Authors:  Stephanie A Orellana; Andrea M Quinones
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 May-Jun       Impact factor: 2.416

Review 5.  Modulation of polycystic kidney disease by G-protein coupled receptors and cyclic AMP signaling.

Authors:  Caroline R Sussman; Xiaofang Wang; Fouad T Chebib; Vicente E Torres
Journal:  Cell Signal       Date:  2020-04-23       Impact factor: 4.315

6.  Cyst formation following disruption of intracellular calcium signaling.

Authors:  Ivana Y Kuo; Teresa M DesRochers; Erica P Kimmerling; Lily Nguyen; Barbara E Ehrlich; David L Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-16       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.